Publishing Details
Contact & Outreach
About This Podcast
Social Media
Explore Statistics
Recent Episodes
Ep. 9: Using AI to Find Novel Treatment Options
SUMMARYIn this episode, Shivu and Kenny discuss how you as a caregiver or patient can use public resources like clinicaltrials.gov and Large Language Models (LLMs) like ChatGPT to discover the latest…
Ep. 8: 2026 Predictions
SummaryIn this episode, Shivu and Kenny review their predictions for 2025 and make new predictions for 2026. They discuss trends in mergers and acquisitions, market performance, the impact of AI in…
Ep.7: Biotech M&A Insights: CVRs, Patent Cliffs & The Pfizer-Novo Bidding War
SUMMARYIn this deep dive into biopharma M&A trends, Shivu and Kenny analyze 10 years of acquisition data from major pharma players, revealing rising deal volumes and the increasing prevalence of…
Ep. 6: Should the FDA Be Independent?
SUMMARY: In this episode, Shivu and Kenny discuss the recent developments surrounding Replimune and its interactions with the FDA. They explore the implications of leadership changes at the FDA, the…
Ep. 5: How to Talk to Doctors | Feat. Joe McCann, Co-Founder/CEO of Slingshot Insights
Summary:In this episode we chat with Joe McCann, CEO of Slingshot Insights. Joe estimates he has done somewhere between 5-10K calls interviewing physicians. In today's episode we tap into his…
Ep.4: Ozempic for the Brain, A New Era to Explain
Summary: In this episode, Shivu and Kenny delve into the evolving landscape of GLP-1 drugs, particularly focusing on the recent advancements in oral formulations and their potential applications…
Ep 3: Rise of the Phoenix | Sujal Shah & CymaBay Therapeutics
A conversation with biotech leader, Sujal Shah, former CEO of CymaBay Therapeutics about his company's story arc, leadership, resilience, and building a biotech company in the face of adversity.…
Ep. 1: Do Pharma Companies Avoid Cures?
In this episode, we unpack, examine, and debunk the public perception that drug companies intentionally do not pursue curative therapies, because it is financially less beneficial to them. We speak…
Ep. 2: Predictions for Biopharma in 2025
Kenny and Shivu each cook up three predictions for Biopharma in 2025NOTE: This episode was recorded on January 10th, 2025Have feedback for us? Leave a comment or email us at…
Ep. 0: Welcome to the Drug Dealin' Podcast!
What is Drug Dealin' going to be about? How are the Drug Dealin' hosts and should you listen to us? What type of content can you expect from this show?Disclaimer: The views and opinions expressed in…
Frequently Asked Questions
Drug Dealin has published 10 episodes since January 2025, covering topics in Life Sciences, Science.
Drug Dealin is currently active with new episodes every 2 months. Average episode length is 1h 12m.
Sign up on Grep.FM to access contact details for Drug Dealin, including email and social media links.
